bioRxivBiophysicsPreprint
Pathogenic Mutations in the C2A Domain of Dysferlin form Amyloid that Activates the Inflammasome.
I. L. Scott, M. J. Dominguez, A. Snow, F. M. Harsini, J. Williams, K. L. Fuson, R. Thapa, P. Bhattacharjee, G. A. Cornwall, P. A. Keyel, R. B. Sutton
Abstract
Limb-Girdle Muscular Dystrophy Type-2B/2R is caused by mutations in the dysferlin gene (DYSF). This disease has two known pathogenic missense mutations that occur within dysferlins C2A domain, namely C2AW52R and C2AV67D. Yet, the etiological rationale to explain the disease linkage for these two mutations is still unclear. In this study, we have presented evidence from biophysical, computational, and immunological experiments which suggest that these missense mutations interfere with dysferlins ability to repair cells. The failure of C2AW52R and C2AV67D to initiate membrane repair arises from their propensity to form stable amyloid. The misfolding of the C2A domain caused by either mutation exposes {beta}-strands, which are predicted to nucleate classical amyloid structures. When dysferlin C2A amyloid is formed, it triggers the NLRP3 inflammasome, leading to the secretion of inflammatory cytokines, including IL-1{beta}. The present study suggests that the muscle dysfunction and inflammation evident in Limb-Girdle Muscular Dystrophy types-2B/2R, specifically in cases involving C2AW52R and C2AV67D, as well as other C2 domain mutations with considerable hydrophobic core involvement, may be attributed to this mechanism.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Circulating miR-4532 is associated with loss of ambulation in dysferlinopathy
Tajveer Singh Grewal, Zsuzsanna Hollander, … Amrit Singh·bioRxiv·Jan 6, 2026
- DAB2 as a biomarker and mechanistic link between lipid dysregulation and disease progression in LGMD R2
Céline Bruge, Nathalie Bourg, … Xavier Nissan·bioRxiv·Sep 11, 2025
- Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients
Veronica Pini, Francesco Catapano, … Francesco Muntoni A·Acta Neuropathologica CommunicationsPeer-reviewed·Feb 3, 2026
- Nerve pathology is prevented by linker proteins in mouse models for LAMA2-related muscular dystrophy
Judith R Reinhard, Emanuela Porrello, … Markus A. Rüegg·PNAS NexusPeer-reviewed·Mar 15, 2023
- Matrix remodeling plays an etiological role in driving laminin-α2 deficient pathology
Veronica Pini, Anthony Accorsi, … Mahasweta Girgenrath·bioRxiv·Jul 2, 2026
- Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy
S. P. Chelko, V. Penna, … J. E. Saffitz·bioRxiv·Jul 12, 2023